STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

NCT03489629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Trimethoprim Sulfamethoxazole (TMP/SMX)
DRUG: Minocycline
DRUG: Mupirocin
DRUG: Chlorhexidine Gluconate
BEHAVIORAL: Environmental Decontamination

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]